BioSig Engages Consulting Firm for Business Model Strategies

Westport, CT, April 04, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ:BSGM) ("BioSig" or the "Company"), a medical technology company delivering unprecedented accuracy and precision to intracardiac signal visualization, announced today that it appointed Bridge Associates International Pharmaceutical Consulting (BAIPC) to advise on business model strategies.  BAIPC will work to deploy a series of solutions to transform BioSig's future course with additional strategies - including operations, sta ...